$CCLD
CareCloud, Inc.

2024 Q2 Form 10-Q Financial Statement

#000149315224019276 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $28.09M $25.96M $30.00M
YoY Change -4.33% -13.46% -15.11%
Cost Of Revenue $15.24M $15.18M $18.11M
YoY Change -12.8% -16.2% -20.13%
Gross Profit $12.85M $10.79M $11.89M
YoY Change 8.06% -9.29% -6.14%
Gross Profit Margin 45.74% 41.54% 39.63%
Selling, General & Admin $5.692M $5.491M $7.732M
YoY Change -33.0% -28.98% -2.97%
% of Gross Profit 44.3% 50.91% 65.03%
Research & Development $1.055M $913.0K $1.078M
YoY Change -10.97% -15.31% 9.44%
% of Gross Profit 8.21% 8.47% 9.07%
Depreciation & Amortization $3.798M $4.020M $3.210M
YoY Change 10.09% 25.23% 4.22%
% of Gross Profit 29.56% 37.27% 27.0%
Operating Expenses $25.82M $25.83M $30.22M
YoY Change -15.76% -14.53% 154.11%
Operating Profit $2.271M $129.0K -$223.0K
YoY Change -276.18% -157.85% -128.81%
Interest Expense -$264.0K -$338.0K -$130.0K
YoY Change -5.71% 160.0% 36.84%
% of Operating Profit -11.62% -262.02%
Other Income/Expense, Net -$294.0K $7.000K $17.00K
YoY Change 58.06% -58.82% -79.52%
Pretax Income $1.713M -$202.0K -$336.0K
YoY Change -197.89% -39.88% -127.91%
Income Tax $39.00K $39.00K $65.00K
% Of Pretax Income 2.28%
Net Earnings $1.700M -$241.0K -$401.0K
YoY Change -192.79% -39.9% -135.18%
Net Earnings / Revenue 6.05% -0.93% -1.34%
Basic Earnings Per Share -$0.14 -$0.02 -$0.28
Diluted Earnings Per Share -$0.14 -$0.02 -$0.28
COMMON SHARES
Basic Shares Outstanding 16.12M shares 16.12M shares 15.51M shares
Diluted Shares Outstanding 16.13M shares 16.01M shares 15.42M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.617M $4.138M $8.200M
YoY Change -66.01% -49.54% -10.25%
Cash & Equivalents $2.617M $4.138M $8.161M
Short-Term Investments
Other Short-Term Assets $2.907M $2.225M $3.400M
YoY Change 0.24% -34.56% -16.05%
Inventory $497.0K $480.0K $265.0K
Prepaid Expenses
Receivables $13.08M $11.96M $14.65M
Other Receivables $16.00K $16.00K $0.00
Total Short-Term Assets $23.92M $24.28M $31.48M
YoY Change -14.02% -22.88% -14.36%
LONG-TERM ASSETS
Property, Plant & Equipment $5.055M $5.438M $4.520M
YoY Change 6.49% 20.31% -62.03%
Goodwill $19.19M $19.19M
YoY Change
Intangibles $21.50M $23.24M $28.54M
YoY Change -23.01% -18.57%
Long-Term Investments
YoY Change
Other Assets $624.0K $641.0K $838.0K
YoY Change -15.33% -23.51% -4.99%
Total Long-Term Assets $50.09M $52.61M $99.54M
YoY Change -49.41% -47.15% -4.7%
TOTAL ASSETS
Total Short-Term Assets $23.92M $24.28M $31.48M
Total Long-Term Assets $50.09M $52.61M $99.54M
Total Assets $74.01M $76.89M $131.0M
YoY Change -41.65% -41.32% -7.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.448M $5.921M $5.191M
YoY Change 5.19% 14.06% -11.01%
Accrued Expenses $6.619M $6.350M $3.728M
YoY Change 68.29% 70.33% -70.55%
Deferred Revenue $1.224M $1.386M $1.394M
YoY Change -1.45% -0.57% 22.28%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $66.00K $167.0K $100.0K
YoY Change 67.0% 5.26%
Total Short-Term Liabilities $23.24M $23.80M $19.20M
YoY Change 18.51% 23.94% -31.66%
LONG-TERM LIABILITIES
Long-Term Debt $5.033M $9.035M $10.00M
YoY Change -49.67% -9.65% 66.17%
Other Long-Term Liabilities $2.491M $2.628M $3.200M
YoY Change -19.65% -17.88% -25.91%
Total Long-Term Liabilities $7.524M $11.66M $13.20M
YoY Change -42.56% -11.64% 27.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.24M $23.80M $19.20M
Total Long-Term Liabilities $7.524M $11.66M $13.20M
Total Liabilities $30.77M $35.47M $32.94M
YoY Change -7.65% 7.67% -15.37%
SHAREHOLDERS EQUITY
Retained Earnings -$73.05M -$74.72M -$26.21M
YoY Change 160.51% 185.11%
Common Stock $17.00K $17.00K $16.00K
YoY Change 6.25% 6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost) $662.0K $662.0K $662.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $43.24M $41.42M $98.08M
YoY Change
Total Liabilities & Shareholders Equity $74.01M $76.89M $131.0M
YoY Change -41.65% -41.32% -7.22%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $1.700M -$241.0K -$401.0K
YoY Change -192.79% -39.9% -135.18%
Depreciation, Depletion And Amortization $3.798M $4.020M $3.210M
YoY Change 10.09% 25.23% 4.22%
Cash From Operating Activities $4.279M $4.066M $1.023M
YoY Change -33.04% 297.46% -66.86%
INVESTING ACTIVITIES
Capital Expenditures $1.603M $298.0K $835.0K
YoY Change -47.27% -64.31% -129.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.603M -$1.868M -$3.039M
YoY Change -47.27% -38.53% 8.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.138M -$1.374M -$1.787M
YoY Change 2.43% -23.11% 422.51%
NET CHANGE
Cash From Operating Activities 4.279M $4.066M $1.023M
Cash From Investing Activities -1.603M -$1.868M -$3.039M
Cash From Financing Activities -4.138M -$1.374M -$1.787M
Net Change In Cash -1.462M $807.0K -$4.138M
YoY Change 111.88% -119.5% 7857.69%
FREE CASH FLOW
Cash From Operating Activities $4.279M $4.066M $1.023M
Capital Expenditures $1.603M $298.0K $835.0K
Free Cash Flow $2.676M $3.768M $188.0K
YoY Change -20.12% 1904.26% -96.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2024Q1 CCLD Provision Benefit For Deferred Income Taxes
ProvisionBenefitForDeferredIncomeTaxes
usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
CY2024Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
usd
CY2024Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
CY2023Q1 CCLD Purchase Of Prepaid Insurance With Assumption Of Note
PurchaseOfPrepaidInsuranceWithAssumptionOfNote
usd
CY2023Q1 CCLD Reclass Of Deposits For Property And Equipment Placed In Service
ReclassOfDepositsForPropertyAndEquipmentPlacedInService
usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
usd
CY2024Q1 us-gaap Accounts Receivable Change In Method Credit Loss Expense Reversal
AccountsReceivableChangeInMethodCreditLossExpenseReversal
usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
308000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
35465000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
6000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16859291 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16620891 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16118492 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15880092 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
17000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
120622000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74722000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3841000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
740799 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
740799 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
662000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
41420000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76885000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25962000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15177000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
18107000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1770000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2612000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3721000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5120000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
913000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1078000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3930000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3038000 usd
CY2024Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
322000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
269000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
25833000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
30224000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
129000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-223000 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
27000 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
20000 usd
CY2024Q1 us-gaap Interest Expense Other
InterestExpenseOther
365000 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
150000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-202000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-336000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-241000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-401000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3931000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-246000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4332000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16014309 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16014309 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15421096 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15421096 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-241000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-401000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
28000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1711000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-213000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2112000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
41717000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-241000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
28000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-79000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
41420000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
101689000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
101689000 usd
CY2023Q1 CCLD Cumulative Effect Of Adoption Of Accounting Standard Update
CumulativeEffectOfAdoptionOfAccountingStandardUpdate
-186000 usd
CY2023Q1 CCLD Stockholders Equity After Adoption
StockholdersEquityAfterAdoption
101503000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-401000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1711000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1185000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1437000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3931000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
98082000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
98082000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-241000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-401000 usd
CY2024Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
4020000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3205000 usd
CY2024Q1 CCLD Amortization Of Lease
AmortizationOfLease
509000 usd
CY2023Q1 CCLD Amortization Of Lease
AmortizationOfLease
683000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
58000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
16000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
37000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
97000 usd
CY2023Q1 CCLD Provision Benefit For Deferred Income Taxes
ProvisionBenefitForDeferredIncomeTaxes
26000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
11000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
11000 usd
CY2024Q1 us-gaap Accretion Expense
AccretionExpense
168000 usd
CY2023Q1 us-gaap Accretion Expense
AccretionExpense
166000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-708000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1072000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
111000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
156000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
361000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
619000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-116000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
615000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
721000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-2556000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4066000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1023000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
298000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
835000 usd
CY2024Q1 CCLD Payments To Capitalized Software And Other Intangible Assets
PaymentsToCapitalizedSoftwareAndOtherIntangibleAssets
1570000 usd
CY2023Q1 CCLD Payments To Capitalized Software And Other Intangible Assets
PaymentsToCapitalizedSoftwareAndOtherIntangibleAssets
2204000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1868000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3039000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
3875000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
151000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1113000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
223000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
236000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1437000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
12700000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10700000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1374000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1787000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-335000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
807000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4138000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3331000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12299000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4138000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8161000 usd
CY2024Q1 CCLD Dividends Declared Not Paid
DividendsDeclaredNotPaid
5000 usd
CY2023Q1 CCLD Dividends Declared Not Paid
DividendsDeclaredNotPaid
3931000 usd
CY2024Q1 CCLD Purchase Of Prepaid Insurance With Assumption Of Note
PurchaseOfPrepaidInsuranceWithAssumptionOfNote
96000 usd
CY2024Q1 CCLD Reclass Of Deposits For Property And Equipment Placed In Service
ReclassOfDepositsForPropertyAndEquipmentPlacedInService
296000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
295000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
75000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
42000000.0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-48700000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9000000.0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-241000 usd
CY2023Q4 CCLD Working Capital
WorkingCapital
-57000 usd
CY2023Q4 us-gaap Cash
Cash
3300000 usd
CY2024Q1 CCLD Working Capital
WorkingCapital
474000 usd
CY2024Q1 us-gaap Cash
Cash
4100000 usd
CY2024Q1 CCLD Dividend Suspended
DividendSuspended
1300000 usd
CY2023Q1 CCLD Allowance For Doubtful Accounts Adoption
AllowanceForDoubtfulAccountsAdoption
186000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
19186000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
61186000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
42000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
19186000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
19186000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
88229000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
86629000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
64992000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
61555000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23237000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25074000 usd
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
3400000 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2500000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8556000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8915000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4533000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
483000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
300000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
450000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23237000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-246000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4332000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16014309 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16014309 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15421096 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15421096 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2024Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3506000 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4030000 usd
CY2024Q1 CCLD Payable To Managed Practices
PayableToManagedPractices
2396000 usd
CY2023Q4 CCLD Payable To Managed Practices
PayableToManagedPractices
593000 usd
CY2024Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
448000 usd
CY2023Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
442000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6350000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5065000 usd
CY2024Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
9000000 usd
CY2023Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
10000000 usd
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
3600000 usd
CY2024Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
100000 usd
CY2024Q1 us-gaap Fair Value Concentration Of Risk Cash And Cash Equivalents
FairValueConcentrationOfRiskCashAndCashEquivalents
155000 usd
CY2023Q4 us-gaap Fair Value Concentration Of Risk Cash And Cash Equivalents
FairValueConcentrationOfRiskCashAndCashEquivalents
255000 usd
CY2024Q1 CCLD Lease Term Description
LeaseTermDescription
Leases with a term of less than 12 months are not recorded in the condensed consolidated balance sheets
CY2023Q1 CCLD Unoccupied Lease Charges
UnoccupiedLeaseCharges
153000 usd
CY2024Q1 CCLD Unoccupied Lease Charges
UnoccupiedLeaseCharges
0 usd
CY2023Q1 CCLD Lease Termination Costs
LeaseTerminationCosts
71000 usd
CY2023Q1 CCLD Additional Costs Of Lease Termination
AdditionalCostsOfLeaseTermination
45000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
637000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
801000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
5000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
5000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
646000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
806000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4107000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4365000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1775000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1888000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2320000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2516000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4095000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4404000 usd
CY2024Q1 CCLD Operating Lease Right Of Use Asset Gross
OperatingLeaseRightOfUseAssetGross
4614000 usd
CY2023Q4 CCLD Operating Lease Right Of Use Asset Gross
OperatingLeaseRightOfUseAssetGross
6571000 usd
CY2024Q1 CCLD Asset Lease Expense
AssetLeaseExpense
-509000 usd
CY2023Q4 CCLD Asset Lease Expense
AssetLeaseExpense
-2152000 usd
CY2024Q1 CCLD Foreign Exchange Gain Loss
ForeignExchangeGainLoss
2000 usd
CY2023Q4 CCLD Foreign Exchange Gain Loss
ForeignExchangeGainLoss
-54000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4107000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4365000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4107000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4365000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.137 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.133 pure
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.137 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.133 pure
CY2024Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
668000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
907000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
249000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
287000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1756000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1350000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
577000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
453000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
385000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1429000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5950000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1855000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4095000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1775000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2320000 usd
CY2024Q1 us-gaap Sublease Income
SubleaseIncome
28000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
0 usd
CY2021Q1 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
750000 usd
CY2021Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
288750 usd
CY2021Q1 CCLD Loss Contingency Unpaid Fees
LossContingencyUnpaidFees
21698 usd
CY2024Q2 CCLD Advance Amount
AdvanceAmount
200000 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
16000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
16000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
6200000 usd
CY2023Q4 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
1300000 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
645000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
322000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
171000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
322000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
228000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
265000 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
645000 usd
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
474000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
171000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
171000 usd
CY2023Q4 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
1300000 usd
CY2024Q1 us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
5400000 usd
CY2024Q1 CCLD Dividends Undeclared
DividendsUndeclared
1300000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25962000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30001000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25962000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30001000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5200000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11888000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5094000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1380000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
256000 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-74000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
361000 usd
CY2024Q1 CCLD Increase Decrease In Contract With Customer Liability Current
IncreaseDecreaseInContractWithCustomerLiabilityCurrent
-6000 usd
CY2024Q1 CCLD Increase Decrease In Deferred Revenue Long Term
IncreaseDecreaseInDeferredRevenueLongTerm
52000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11962000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5455000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1386000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
308000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14773000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4399000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1386000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
342000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
127000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
619000 usd
CY2023Q1 CCLD Increase Decrease In Contract With Customer Liability Current
IncreaseDecreaseInContractWithCustomerLiabilityCurrent
-8000 usd
CY2023Q1 CCLD Increase Decrease In Deferred Revenue Long Term
IncreaseDecreaseInDeferredRevenueLongTerm
8000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14646000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5018000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1394000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
350000 usd
CY2024Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
90000 usd
CY2023Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
167000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
39000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
26000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
879000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
823000 usd
CY2023 us-gaap Accounts Receivable Change In Method Credit Loss Expense Reversal
AccountsReceivableChangeInMethodCreditLossExpenseReversal
186000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
37000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
454000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
107000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
691000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
917000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
879000 usd
CY2024Q1 CCLD Number Of Cashsetttled Awards
NumberOfCashsetttledAwards
17754 shares
CY2024Q1 CCLD Liability For Cash Settled Amount
LiabilityForCashSettledAmount
80000 usd
CY2023Q1 CCLD Liability For Cash Settled Amount
LiabilityForCashSettledAmount
767000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-708000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1072000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39000 usd
CY2024Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
30000 usd
CY2024Q1 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
9000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25962000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15177000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1770000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3721000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
913000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3930000 usd
CY2024Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
322000 usd
CY2024Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
322000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
25833000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
129000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30001000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
18107000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2612000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5120000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1078000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3038000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
269000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
269000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
30224000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-223000 usd

Files In Submission

Name View Source Status
0001493152-24-019276-index-headers.html Edgar Link pending
0001493152-24-019276-index.html Edgar Link pending
0001493152-24-019276.txt Edgar Link pending
0001493152-24-019276-xbrl.zip Edgar Link pending
ccld-20240331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
ccld-20240331_def.xml Edgar Link unprocessable
ccld-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ccld-20240331_lab.xml Edgar Link unprocessable
ccld-20240331_cal.xml Edgar Link unprocessable